FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy

Dermatologic Surgery

Volumn 33, Issue 9, 2007, Pages 1037-1044

  Almeida, Jose I ^a   Raines, Jeffrey K ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami Vein Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROSING AGENT; TETRADECYL SULFATE SODIUM; POLIDOCANOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG IMPURITY; DRUG MANUFACTURE; DRUG PURITY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCLEROTHERAPY; VEIN DISEASE; CLINICAL PRACTICE; NOTE; UNSPECIFIED SIDE EFFECT;

DRUG APPROVAL; DRUG COMPOUNDING; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLEROSING SOLUTIONS; SODIUM TETRADECYL SULFATE; UNITED STATES; VENOUS INSUFFICIENCY;

EID: 34548309220     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33217.x     Document Type: Article

References (14)

1. Almeida JI, Raines JK. Radiofrequency ablation and laser ablation in the treatment of varicose veins. Ann Vasc Surg 2006 20 : 547 52.
2. Guex JJ. Indications for the sclerosing agent polidocanol. J Dermatol Surg Oncol 1993 19 : 959 61.
3. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004 30 : 718 22.
4. Hamel-Desnos C, Desnos P, Wollmann JC, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003 29 : 1170 5.
5. Goldman MP. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe? Dermatol Surg 2004 30 : 1454 6.
6. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005 31 : 631 5.
7. Almeida JI, Raines JK. Radiofrequency versus laser versus chemical sclerotherapy for endoablation of the saphenous vein and when you do not need to do stab avulsions. Vascular 2005 13 (S1) : S16.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53 : 457 81.
9. Cabrera J, Cabrera J Jr., Garcia-Olmedo MA. Sclerosants in microfoam: a new approach in angiology. Int Angiol 2001 20 : 322 9.
10. Masuda EM, Kessler DM, Lurie F, et al. The effect of ultrasound-guided sclerotherapy of incompetent perforator veins on venous clinical severity and disability scores. J Vasc Surg 2006 43 : 551 6.
11. Guex JJ. Foam Sclerotherapy: an overview use for primary venous insufficiency. Semin Vasc Surg 2005 18 : 25 9.
12. Breu FX, Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany. Dermatol Surg 2004 30 : 709 17.
13. Guex JJ. Indications for the sclerosing agent polidocanol. J Dermatol Surg Oncol 1993 19 : 959 61.
14. Guex JJ. Foam Sclerotherapy: an overview use for primary venous insufficiency. Semin Vasc Surg 2005 18 : 25 9.